Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market
Holding GRCL?
Track your performance easily

Gracell Biotechnologies (GRCL) Stock Investors

134 Followers
Based on 716,948 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GRCL
On average, investors allocate 0.00% of their portfolios to GRCL
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 716,948 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GRCL

1.2%
Last 7
Days
4.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GRCL, out of 716,948 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GRCL Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 13,388 investors who made their portfolios public
The table shows changes in GRCL in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GRCL Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
UiPath
3.53%
+0.42%
+8.37%
12.96B
Technology
ChargePoint Holdings
3.99%
-0.84%
-1.96%
806.79M
Consumer Cyclical
DraftKings
7.20%
-0.03%
+6.18%
35.32B
Consumer Cyclical
Coherus Biosciences
2.64%
-1.10%
-3.76%
276.18M
Healthcare
Micron
5.26%
+0.65%
+4.68%
89.96B
Technology
Coinbase Global
7.94%
+1.74%
+5.79%
39.35B
Financial
Merck & Company
4.18%
+0.22%
+3.94%
324.66B
Healthcare
AMC Entertainment
5.38%
-0.67%
-2.39%
1.20B
Communication Services
Marathon Digital Holdings
5.95%
+0.47%
+6.21%
5.10B
Financial
C3ai
5.34%
-0.62%
-1.01%
3.14B
Technology
Based on the activity of 716,948 active portfolios
Open your Smart Portfolio

GRCL Investor Analysis

GRCL investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.0%
of GRCL holders
are under 35
Average Segment Performance
Average P/E Ratio12.71
Beta7.27
Dividend Yield5.47%
GRCL investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
56.7%
of GRCL holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.96
Beta11.07
Dividend Yield5.92%
GRCL investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.3%
of GRCL holders
are over 55
Average Segment Performance
Average P/E Ratio6.89
Beta5.88
Dividend Yield5.37%
Overview of age group and performance of GRCL stock investors
See who invests in GRCL according to age group and performance.

FAQ

How many retail Investors hold GRCL?
<0.1% of TipRanks' retail investors hold GRCL in their portfolios.
    What is GRCL Investor Sentiment?
    GRCL’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GRCL in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of GRCL in the last 7 days.
        What percentage of retail investors changed their holding of GRCL in the last 30 days?
        ▼ 4.0% of TipRanks' retail investors changed their holding of GRCL in the last 30 days.
          What is the average age of retail investors who hold GRCL?
          The average age of GRCL Holders is between 35–55.
            What other stocks have GRCL investors also bought?
            GRCL Investors also bought PATH, CHPT, DKNG, CHRS, MU, COIN, MRK, AMC, MARA, AI.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              CORCencora
              BSXBoston Scientific
              CAHCardinal Health
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis